Vertex 8. Juni 2026 Kyverna vs. Vertex: Clinical-Stage Risk vs. Cash-Flow Stability in Biotech Investing - News and Statistics - IndexBox
Vertex 21. Mai 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes new growth drivers after latest pipe - AD HOC NEWS
Vertex 20. Mai 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes gene-editing future - AD HOC NEWS
Vertex 19. Mai 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader after solid quarterly results - AD HOC NEWS
Vertex 18. Mai 2026 Vertex Pharma stock (US92532F1003): focus on cystic fibrosis and expanding pipeline - AD HOC NEWS
Vertex 12. Mai 2026 Vertex Pharma stock (US92532F1003): Earnings highlight pain drug advances - AD HOC NEWS
Vertex 12. Mai 2026 A year after Vertex’s big launch, pain drug research faces a pivotal moment - BioPharma Dive
Vertex 6. Mai 2026 Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy (VRTX) - Seeking Alpha
Vertex 2. Mai 2026 Bank of America Names Vertex Pharmaceuticals Top Biotech Pick for 2026 - HarianBasis.co